Pure Global

PROs Following Low-dose Irradiation for Osteoarthritis - Trial NCT05705947

Access comprehensive clinical trial information for NCT05705947 through Pure Global AI's free database. This phase not specified trial is sponsored by University of North Carolina, Chapel Hill and is currently Recruiting. The study focuses on Osteoarthritis. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05705947
Recruiting
Trial Details
ClinicalTrials.gov โ€ข NCT05705947
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
PROs Following Low-dose Irradiation for Osteoarthritis
Patient Reported Outcomes Following Low-dose Irradiation for Osteoarthritis (PRO-LO): A Single-arm Prospective Registry

Study Focus

Osteoarthritis

Observational

Sponsor & Location

University of North Carolina, Chapel Hill

Chapel Hill, United States of America

Timeline & Enrollment

N/A

Mar 01, 2023

Apr 01, 2034

40 participants

Primary Outcome

Change in Visual Analog Pain Scale (VAPS) Score from Baseline to M3 Post Radiation Treatment Completion

Summary

The goal of this observational registry study is to collect data related to patient reported
 outcomes (pain, function, quality of life, toxicity) in osteoarthritis (OA) patients
 receiving standard of care radiation therapy (RT).

ICD-10 Classifications

Other hypertrophic osteoarthropathy
Other specified osteochondropathies
Polyarthritis, unspecified
Other osteochondropathies
Osteochondritis dissecans

Data Source

ClinicalTrials.gov

NCT05705947

Non-Device Trial